Athira Pharma, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Athira Pharma, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Athira Pharma, Inc. Depreciation for the quarter ending September 30, 2024 was $243K, a 0.41% decline year-over-year.
  • Athira Pharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $972K, a 0.94% increase year-over-year.
  • Athira Pharma, Inc. annual Depreciation for 2023 was $969K, a 14.7% increase from 2022.
  • Athira Pharma, Inc. annual Depreciation for 2022 was $845K, a 76.4% increase from 2021.
  • Athira Pharma, Inc. annual Depreciation for 2021 was $479K, a 23850% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $969K +$124K +14.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $845K +$366K +76.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $479K +$477K +23850% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $2K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $2K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.